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1. Introduction
Antimicrobial resistance (AMR) is one of the most 
relevant concerns of modern medicine worldwide: 
these drugs, considered as panacea for the treat-
ment of previously deadly infections are losing 
their effectiveness, resulting in increased mortali-
ty rate and decreased quality of life in the affected 
patient population [1,2]. The withdrawal of major 
pharmaceutical companies from the field of anti-
microbial R&D means that healthcare profession-
als have to make due with the drugs that are al-
ready available [3,4]. In fact, one of the main re-
quirements for even the “Health for all by 2000” 
(World Health Organization, 1981) was the avail-
ability of effective antibiotics: therefore, one of the 
main setbacks of this program was the rapid glob-
al emergence of AMR [5,6]. The situation of antibi-
otic availability has not improved substantially 
since the beginning of the 21st century; in a current 
report from the WHO, the lack of novel antibiotic 
has once again been cited as a significant threat to 
medicine [7]. Infections caused by resistant bacte-
rial pathogens are also sources of significant fi-
nancial losses (both corresponding to increased 
expenses for the healthcare infrastructure and loss 
of profits from decreased productivity): in the 
United States, these financial losses have been es-
timated to be around 50-60 billion US dollars, 
while in the European Union, these figures may 
go up as high as 1.5 billion euros [1,8].
Hungary ranks low in the total consumption of 
antibiotics (ABs) in Europe, both in the communi-
ty and in hospital settings (with a consumption of 
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15.4 and 1.18 defined daily doses [DDD] per 1000 
inhabitants per day, respectively, based on the lat-
est data of the ECDC [EU/EEA average: 21.9 and 
2.06 DDD per 1000 inhabitants per day, respec-
tively], however, the country is a leader in the 
consumption of broad-spectrum agents (predomi-
nantly fluoroquinolones) instead of narrow-spec-
trum drugs [9,10]. The correlation between the 
levels of AB use (including self-medication with 
ABs) and the development and spread of resistant 
bacteria has been highlighted by several publica-
tions worldwide [11]. Although the relationship is 
complex, the increased utilization of ABs drives 
increases in resistance levels; therefore, the pru-
dent use of these agents is of utmost importance 
[12]. In addition to the responsibility of various 
healthcare professionals (HCPs) (i.e. the compli-
ance of prescribing physicians, pharmacists, nurs-
es with national and international guidelines and 
regulations, restriction of non-prescription AB 
sales, proper instructions given by HCPs [13-17]), 
the populations’ knowledge and attitudes on AB 
use and resistance has been shown to significantly 
influence antibiotic consumption worldwide [18].
Apart from the knowledge of the general popu-
lation, the social aspects of AMR and improper 
antibiotic use are increasingly being recognized as 
an important facet of this issue: the insufficient so-
cial awareness of antibiotic resistance may lead to 
exaggerated expectations for AB prescriptions 
from the public; in addition, the socio-economic 
status, education level, residential background, 
cultural factors, vulnerable population status, des-
perate need to maintain employment despite the 
presence of symptoms of bacterial diseases or dis-
crimination may all influence behavioural biases, 
health literacy and health-related decision-making 
processes in the general population [19,20]. These 
issues are usually addressed via awareness-rais-
ing and educational campaigns, both aimed at 
HCPs and the public. Among the campaigns with 
the largest impact, the European Antibiotic 
Awareness Day (EAAD; 18th of November) orga-
nized by the European Centers for Disease Con-
trol and Prevention (ECDC) and the World Antibi-
otic Awareness Week (18-24th of November in 
2019) by the WHO are among the most notable. 
Preceding research on the treatment-seeking 
behaviors and attitudes of the European popula-
tion has prompted our research interest to investi-
gate current trends in our local setting [21]. The 
aim of our present study was to assess the knowl-
edge level and attitudes of patients (general popu-
lation) towards AB and AMR, in addition to their 
practices towards the procurement and use of 
these drugs in the Szeged District of Hungary.
2. Materials and methods
2.1. Sample size and study location
A cross-sectional, questionnaire-based pilot study 
was performed among patients aged 18 years or 
older in the Szeged District. The Szeged District is 
located in Csongrád County, in the Southern 
Great Plain of Hungary; with an area of ~741 km2, 
it is the second largest district in the county, con-
taining thirteen inhabited places (ten villages, one 
large village and two cities). The population of the 
county is around 204,000 people, as per most re-
cent census data (population density: 276/km2). 
The study population comprised of adult pa-
tients attending their general practitioner’s (GP) 
offices in the District. Sample size for the adult 
population of the Szeged District was calculated 
by using the Raosoft sample size calculator [22], 
based on the formula below (1): population was 
N=169,300 (83% of the total population is aged 18 
or older, as per most recent census data), x was 
confidence interval of 95%, E was the a margin of 
error set at 5% and the expected response rate set 
at 50%, based on the results of the Special Euroba-
rometer 407 [21]. The minimum sample size of 
n=103 (n=94 with an added contingency of 10% for 
non-responders and inappropriate responses) was 
set for the completion of this pilot survey.
n=N (N-1)E2+x
x
 (1)
A total of 218 patients in five GPs’ offices 
throughout the Szeged District were approached 
with our questionnaire, out of which 113 chose to 
participate in our survey (corresponding to a re-
sponse rate of 51.9%, females were more inclined 
to participate). Four respondents (1.5%) were ex-
cluded due to incompletely filled out question-
naires; therefore n=109 were included in the final 
analysis. 
2.2. Structure of the questionnaire
A literature review of similar surveys was con-
ducted in the PubMed/MEDLINE database in or-
der to identify potential questions for the develop-
ment of the instrument in this study; in addition, 
some of the questions were based on the questions 
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of the Eurobarometer Survey 407 [21]. The ques-
tionnaire was adapted in accordance with local 
population characteristics and the questionnaires 
were developed in Hungarian language. The ques-
tionnaire was then reviewed and assessed by 
three faculty members (with extensive experience 
in survey research), a GP, a community pharma-
cist and a public health specialist for content and 
face validation and to ensure the clarity and ease 
of use during the survey. Minor modifications (re-
wording, reformatting or reordering of questions) 
were performed based on the comments of the 
evaluation panel. 
The final structured questionnaire consisted of 
33 questions covering three major areas: Part I. de-
mographic characteristics and health status (nine 
items: age, sex, highest level of education, place of 
residence, employment status, subjective evalua-
tion of health status, existence of chronic illnesses, 
reason for present GP-visit); Part II.: questions 
about the use and the procurement of ABs and the 
roles of HCPs in the eyes of the respondents (four-
teen items); this section included single-choice, 
multiple-choice and open-ended questions, re-
spectively. In addition, some of the questions had 
follow-up questions, therefore respondents were 
asked to fill out or skip specific questions depend-
ing on their answers; Part III.: questions on the 
knowledge and attitudes of the patients (five-five 
items each), adopted from the Eurobarometer sur-
vey: at the statements evaluating the respondents’ 
knowledge on ABs, they had the option of choos-
ing between ‘True’, ‘False’, and ‘I don’t know/Un-
sure about the answer’, while during statements 
aiming to measure the attitude of respondents, a 
five-point Likert-scale ranging from “Strongly 
agree” to “Strongly disagree” was used to record 
the responses of the participants. Questions QK1-
QK4 (see Table 3) were used to create a composite 
knowledge-score (ranging between 0-4 for each 
correct statement) to allow for comparison with 
the results of the Eurobarometer surveys.
2.3. Data collection, statistical analysis
Data collection for the survey was running be-
tween January 2016 and January 2018. Prior to par-
ticipating in the survey, the nature and purpose of 
the study was explained to the patients, including 
the data collection methods and that participation 
was voluntary. Participants were informed that 
the data collection, processing and analysis are 
anonymous. Data collectors also made sure that 
the patients did not participate in the Eurobarom-
eters regarding ABs in parallel (Special Euroba-
rometer 445: field work between April-May 2016; 
Flash Eurobarometer 444: field work between Sep-
tember-October 2016, respectively) [23]. No renu-
meration or gifts were given to participants to fa-
cilitate them to take part in the survey. 
All questionnaires were checked manually and 
questionnaires with >90% completion were includ-
ed in the analysis. All the completed question-
naires were entered into Epi-data version 3.1 and 
the data was exported to SPSS (Statistical Package 
for the Social Sciences) Statistics version 23.0 (IBM; 
Chicago, IL, USA) for data analysis. Descriptive 
statistics were used to analyze qualitative vari-
ables, while quantitative variables were summa-
rized using mean ± standard deviation (±SD). Uni-
variate analysis was performed using Pearsons’s 
Chi-squared tests or Fisher’s exact tests when 
comparing proportions, while Student’s t-tests 
were utilized to assess the association between nu-
merical values. All statistical tests were two-tailed, 
and results were considered to be statistically sig-
nificant if p<0.05.
2.4. Ethical approval
The survey was conducted in accordance with the 
Declaration of Helsinki and national and institu-
tional ethical standards. Ethical approval for the 
study protocol was obtained from the Regional 
and Institutional Human Medical Biological Re-
search Ethics Committee of the Szent-Györgyi Al-
bert Clinical Centre, University of Szeged (regis-
tration number: 3688).
3. Results
3.1. Demographic characteristics, health status of 
respondents
The socio-demographic characteristics of the re-
spondents are presented in Table 1. The median 
age of the respondents was 51 years (50.8±17.8 
years, range: 19-93). The majority of respondents 
were from the seat of the district and the county 
(Szeged; n=62; 56.9%), while other respondents 
were from villages (43.1%; Domaszék n=41, 
Szatymaz n=2, Deszk, Kistelek, Kiskundorozsma, 
Zákányszék n=1, respectively). Among the respon-
dents, females (60.6%) and patients with the sec-
ondary-level education (61.5%) were represented 
in higher numbers.
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The respondents evaluated their current health 
status as bad in 9.3% of cases (2.8% and 6.5% for 
very bad and bad, respectively), while 41.7% re-
sponded with moderate and 51.9% with good 
(46.3% and 5.4% for good and very good, respective-
ly) 53.7% (n=59) reported having a chronic illness 
which requires medical attention/pharmacothera-
py (or has required therapy in the last 12 months): 
51.7% of these patients reported one chronic dis-
ease, while 31.2%, 13.7% and 3.4% reported suffer-
ing from two, three and four chronic ailments re-
spectively. The self-reported chronic illnesses 
were diseases of the cardiovascular system 
(30.4%), diabetes (type I and II; 21.8%), diseases of 
the locomotor system (16.3%), endocrine system 
(7.6%), pulmonary system (7.6%), kidney disease 
(5.4%), gastrointestinal system (5.4%), autoim-
mune disorders (2.2%), psychiatric disorders 
(2.2%) and malignant illness (1.1%). A significant 
association was found between the self-reported 
health status and the presence of chronic illnesses 
(p<0.0001), but not between age and chronic ill-
nesses (p>0.05).
36.0% of respondents have visited the GPs’ of-
fice to procure a prescription for themselves or 
their family members, 31.3% due to an acute ill-
ness, 19.6% were on their follow-up visit, 5.5% 
came for the administration of a medicine or vac-
cine, 4.8% visited for a routine check-up (for em-
ployment purposes or for driving licenses), while 
2.8% came for a referral letter to visit a specialist.
3.2. Antibiotic use, sources of antibiotics 
80.7% (n=88) of respondents stated that they visit 
the GPs offices 0-2 times a year due to an infec-
tious disease, while 14.7% (n=16) reported 3-4 and 
4.6% (n=5) reported more, than 4 occasions, re-
spectively. Patients were surveyed on the last time 
they took ABs (results are presented in Table 2): al-
most one-third (32.1%) has taken these drugs dur-
ing the last 12 months. 90.5% (n=99) of respon-
dents has obtained their last course of ABs 
through a medical prescription, 1.9% (n=2) had it 
administered by a medical practitioner, 4.8% (n=5) 
used leftover drugs from a previous course of 
therapy, while 2.8% (n=3) obtained it from a phar-
macy, without a medical prescription.
By their own admission, 31.6% of respondents 
stated that the last time they took ABs was to treat 
sore throat, while 14.0% has taken them for a uri-
nary tract infection, 13.2% to treat a cold, 7.4% for 
bronchitis, 6.6% to treat a flu or a persistent cough, 
5.1% for pneumonia, 4.4% took it prophylactically 
after surgery, 2.9% took them after a dental proce-
dure, 2.2% took them due to a skin and soft tissue 
infection or to treat diarrhoea and 1.5% took ABs 
to alleviate fever. 
Patients were asked about their sources of infor-
mation on ABs (multiple answers were allowed): 
medical doctors were perceived as the most trust-
worthy sources (70.6%), followed by community 
pharmacists (23.9%), the Internet (20.2%), previous 
secondary school/university education (19.3%), 
television and/or radio (18.3%), books, newspapers 
or information pamphlets (17.4%), family mem-
bers (10.1%), friends or acquaintances (7.3%), other 
Table 1 Demographic characteristics of the participants
Characteristics n (%)
Gender
Female 66 (60.6%)
Male 43 (39.4%)
Age  
18-35 years 27 (24.4%)
36-64 years 50 (45.8%)
65 years or older 32 (29.8%)
Place of residence  
Urban 62 (56.9%)
Provincial 47 (43.1%)
Level of education
Elementary school 12 (11.0%)
Trade school 28 (25.7%)
Secondary school 18 (16.5%)
Grammar school 21 (19.3%)
College/University 30 (27.5%) 
Employment status
Employed 50 (45.9%)
Unemployed/Looking for a job 6 (5.5%)
Pensioner 38 (34.9%)
Rehabilitation 2 (1.8%)
Disability pension 3 (2.7%)
Childcare benefit/allowance 3 (2.7%)
Student 7 (6.5%)
Table 2 Responses to the question ‘When was the last time 
you took antibiotics?’
Last use of antibiotics n (%)
I have never taken antibiotics. 4 (3.7)
More than 5 years ago. 20 (18.3)
1-5 years ago. 29 (26.6)
In the last 12 months. 35 (32.1)
In the last month. 10 (9.2)
I am currently taking antibiotics. 5 (4.6)
I don’t know/I don’t remember. 6 (5.5)
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healthcare-professionals, e.g., pharmacy assistants, 
nurses, health-promotion specialists (2.8%) and 
other sources (e.g. medicines information leaflet; 
1.8%). There were no significant association be-
tween age or gender  and the reported source of 
information (p>0.05). One third of patients (34.9%; 
n=38) have recalled receiving information about 
not taking antibiotics unnecessarily: most of these 
respondents got this information from their physi-
cians (55.9%), in addition, community pharma-
cists, family members (11.8%, respectively), the In-
ternet (8.8%), friends or acquaintances and the In-
ternet (5.9%) were also identified. 88.2% (n=30) of 
these patients chose to take this advice seriously. 
Older patients recalled receiving information on 
this topic much less frequently (p=0.021).
In addition, patients were asked about their ad-
herence to the medical advice from their respec-
tive HCPs: 65.1% stated that they always and com-
pletely follow the instructions of the physicians, 
while 33.9% stated that they generally take these 
instructions into account; complete adherence to 
the instructions of the community pharmacists 
was reported in 45.5%, while generally good ad-
herence in 47.5% of respondents. Only a minority 
of respondents (0.9% regarding physicians’ and 
7.1% for pharmacists’ instructions) stated that 
they generally do not follow the instructions of 
their respective healthcare-providers. 73.1% (n=79) 
considered the purchase of additional medications 
or adjuvants (e.g., probiotics) with antibiotics if 
the pharmacist recommends it. 4.6% (n=5) of pa-
tients reported trying to obtain antibiotics from a 
community pharmacist without a prescription, 
bypassing their physicians; 1.8% (n=2) of respon-
dents successfully obtained these drugs from a 
pharmacy. Additionally, 17.8% agreed (5.9% , 
7.9% ), that they would be able to source antibiot-
ics without a medical prescription, if there were a 
need for it (53.5% and 22.8%  with this statement, 
while 9.9% was  of the answer). This was more 
prevalent in respondents from Szeged (p=0.023), 
than from respondents from surrounding villages.
3.3. Knowledge and attitude about antibiotics, socio-
demographic and key variable analysis
The responses for the knowledge-based questions, 
adapted from the Eurobarometer survey are pre-
sented in Table 3. 18.3% (n=20) of respondents gave 
correct answers to all relevant questions (QK1-
QK4), while 7.3% (n=8) had zero correct answers; 
the highest number of respondents could answer 
two questions (43.1%; n=47) correctly. The average 
number of correct answers overall were 2.11±1.16; 
there were no statistically significant differences 
among the results of respondents from Szeged 
(2.27±1.10) and respondents from the surrounding 
villages (1.89±1.19; p>0.05). Similarly, no correla-
tion was found between the number of correct an-
swers and age, current health status, presence/ab-
sence of chronic illness, employment status or 
number of GP visits per year (p>0.05). There was, 
however, association found with the highest level 
of education (p<0.001); the same association was 
also found when considering the number of cor-
rect answers to QK5 (p=0.029). In addition, re-
spondents who reported to use antibiotics for in-
appropriate indications (e.g., sore throat, cold, flu, 
fever) had worse results in the knowledge-based 
questions (QK1-4 p=0.03; QK5 p=0.047).
The respondents’ beliefs regarding ABs and 
prevention (questions QA1-5) are summarized in 
Table 4. Of note, 75% of respondents believe that 
ABs are medicines of special importance (QA1); 
there was no correlation between this positive 
Table 3 Statements measuring respondents’ knowledge on ABs
True
n (%)
False
n (%)
Unsure of the 
answer
n (%)
QK1 Antibiotics are effective against viruses.  
(Correct answer: False) 56 (51.4%) 35 (32.1%) 18 (16.5%)
QK2 Antibiotics are effective therapy for the common cold and the flu.  
(Correct answer: False) 50 (46.3) 43 (39.8%) 15 (13.9%)
QK3 Unnecessary and inappropriate (in dose or duration) use of antibiotics 
makes them become ineffective.  
(Correct answer: True)
86 (78.9%) 7 (6.4%) 16 (14.7%)
QK4 Taking antibiotics often has side-effects such as diarrhea. 
(Correct answer: True) 74 (65.1%) 17 (15.6%) 21 (19.3%)
QK5 When my symptoms are gone, I may stop taking the antibiotic safely. 
(Correct answer: False) 38 (34.8%) 65 (59.6%) 6 (5.6%)
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statement and the participant’s age, gender or the 
number of correct answers (see previous section), 
however, participants with higher levels of educa-
tion (p=0.048) and those, who reportedly visit the 
GP’s office more frequently due to infections ail-
ments (p=0.021) were more likely to have such be-
liefs. Only 64.8% of the respondents regarded 
their knowledge about infectious diseases as ap-
propriate (QA2). Interestingly, women were more 
satisfied with their knowledge-level (p<0.001), 
while satisfaction-level and the number of correct 
answers showed no association (p>0.05). In a simi-
lar fashion, women were more likely to be dissat-
isfied with the involvement of the media in dis-
seminating relevant information on infectious dis-
eases to the public (QA5; p=0.024); although 44.9% 
agreed and 39.3% of the patients disagreed with 
the statement. All respondents agreed on the role 
of personal hygiene and personal care (100%) in 
infectious disease-prevention, however, the role of 
vaccines in this regard was clear to only 77.8% of 
participants (QA3 and QA4, respectively).
4. Discussion
In the present study, the knowledge level and atti-
tudes of patients towards ABs and antibiotic resis-
tance, in addition to their drug utilization practic-
es were assessed in the Szeged District of Hunga-
ry. We have found that around 32% of respondents 
have taken ABs in the last 12 months, mainly for a 
sore throat. They identified healthcare profession-
als as the most trustworthy sources of informa-
tion, moreover they generally follow their advices; 
while the Internet also emerged as an important 
information source, verifying the results of previ-
ous reports [24]. Just minority (4.8%) used leftover 
ABs for their last course, and 2.8% accessed to 
non-prescribed ABs from a pharmacy. This latter 
is in line with the result of a European study, 
where 1-9% of the population was identified gen-
erally to obtain ABs without a prescription from a 
pharmacy [25]. Regarding the knowledge level of 
the respondents, we have found that most patients 
were aware of the emergence of bacterial resis-
tance and the potential adverse events that may 
occur during AB use, however, many respondents 
identified colds, the flu and viral infections in gen-
eral as indications for AB therapy. Based on our 
results, correlation was found between the highest 
level of education, AB-related knowledge and the 
appreciation of the role of ABs in healthcare, 
which is line with other reports available in the 
literature [26,27]. 
The methodology and instrument used for this 
survey was based and adapted from the Euroba-
rometer survey on AMR by the European Com-
mission, one of the two most important interna-
tional studies, the Special Eurobarometer reports 
(Flash EBM 444 [28] in 2016, EBM 445 [23] in 2016 
and EBM 478 in 2018 [39], respectively) commis-
sioned by the European Union, and the ‘Antibiotic 
Resistance: Multi-country awareness survey’ for 
non-EU countries, performed by the WHO [30]. 
The highlights of the abovementioned reports are 
summarized in Table 5, serving as a contrast to the 
results of the present study. The average number 
of correct answers in the study region (2.1) was in 
line with previous reports of the Hungarian na-
tional average (in the EBMs 338, 407 and 445), 
however, in the last EBM, both the European over-
all average and the national average of Hungary 
has increased (2.6 and 2.3, respectively) [21,23,28-
30].
Table 4 Patients’ attitudes towards antibiotics and preventative measures to avoid contracting infectious diseases
Statements
SD D
U/DK
n (%)
A SA
Disagree
n (%)
Agree
n (%)
QA1 Antibiotics are medicines of special im-
portance. 5 (4.6%) 11 (10.2%) 11 (10.2%) 37 (34.3%) 44 (40.7%)
QA2 My knowledge regarding infectious 
diseases is appropriate. 3 (2.8%) 20 (18.5%) 15 (13.9%) 48 (44.4%) 22 (20.4%)
QA3 Personal hygiene and taking care of our-
selves have important roles in the prevention 
of infectious diseases. 
1 (0.9%) 0 (0%) 0 (0%) 26 (23.9%) 82 (75.2%)
QA4 Vaccines are an important means of 
preventing infectious diseases. 8 (7.4%) 6 (5.6%) 10 (9.3%) 31 (28.7%) 53 (49.1%)
QA5 The media devotes enough energy to dis-
seminate information on infectious diseases. 16 (15.0%) 26 (24.3%) 17 (15.9%) 29 (27.1%) 19 (17.8%)
SD: strongly disagree, D: disagree, U/DK: I don’t know/Unsure, A: agree, SA: strongly agree
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By the recommendations of the European Sur-
veillance of Antimicrobial Consumption Network 
(ESAC-Net), AB use in adults is only indicated in 
around 0-30% of cases in upper respiratory tract 
infections, acute tonsillitis, acute or chronic sinus-
itis, acute otitis media, acute bronchitis or bronchi-
olitis, while for acute cystitis and pneumonia, this 
ratio is 80-100% [10,11]. Several national and inter-
national studies have described gaps in public 
knowledge and issues regarding inappropriate AB 
use [11,18,31-34], characterized by their procure-
ment through non-prescription (predominantly 
Table 5 Summary of the findings of the Special Eurobarometer reports (EU) and the ‘Antibiotic Resistance: Multi-country 
awareness survey’ (WHO) on AB-related knowledge and AB utilization [21,23,28-30].
Survey 
(Year)
Anti biotics 
in the last 12 
months (EU)
Source of 
antibiotics 
(EU)
Anti-
biotics 
taken 
for the 
flu
Anti-
biotics 
taken to 
treat a 
cold
Average 
number 
of correct 
answers 
(EU)
Anti-
biotics 
are 
effective 
against 
the cold 
and flu
Anti-
biotics 
are 
effetive 
against 
viruses
All answers 
(n=4) are 
correct
EBM 407 
(2013)
[21]
35%;  
highest in 
Malta (48%), 
lowest in 
Sweden (24%)
From a medical 
prescription/
pharmacy: 
95%; 3% from 
a pharmacy, 
without a 
prescription; 
2% leftover 
from home
18% 13%
2.4  
(Hunga-
ry: 2.1); 
highest in 
Sweden 
(3.1), 
lowest in 
Romania 
(1.5)
41% 49% 22%
EBM 445 
(2016)
[23]
34%;  
highest in 
Malta (48%), 
lowest in 
Sweden (18%)
From a medical 
prescription/
pharmacy: 
93%; 4% from 
a pharmacy, 
without a 
prescription; 
3% leftover 
from home
16% 11%
2.5 
(Hunga-
ry: 2.2); 
highest in 
Finland 
(3.1), 
lowest in 
Italy (1.9)
44% 43% 24%
EBM 478 
(2018)
[29]
32%;  
highest in Italy 
(47%), lowest 
in Sweden 
(20%)
From a medical 
prescription/
pharmacy: 
93%; 3% from 
a pharmacy, 
without a 
prescription; 
4% leftover 
from home
12% 8%
2.6  
(Hunga-
ry: 2.3); 
highest in 
Finland 
and 
Sweden 
(3.1), 
lowest in 
Romania 
and Latvia 
(2.1)
48% 28% 25%
WHO 
Multi-
country 
survey 
(2015)
[30]
35%;  
higher in 
lower income 
countries 
(42%), lower in 
higher income 
countries 
(29%)
From a medical 
prescription/
pharmacy: 
93%; 2% from 
a pharmacy, 
without a 
prescription; 
2% leftover 
from home; 3% 
from a friend or 
family member, 
1% from the 
Internet
- - - 64% - -
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from pharmacies) and non-medical (leftover 
drugs, drugs from family members or friends) 
sources. These studies have all highlighted the 
role of self-medication of antibiotics as a minor 
(0.5-8%), but still significant portion of AB con-
sumption. In addition, the ignorance (risk-taking 
behaviour) or lack of understanding towards in 
ineffectiveness of ABs against viral infections (and 
the common cold) was also identified in a plethora 
of publications: many people identify all disease-
causing pathogens as “germs”, not distinguishing 
their biological characteristics and the subsequent 
therapeutic approach needed to treat them 
[11,18,31-34]. 
Educational campaigns and behavioural AMR 
strategies are essential to address both the knowl-
edge-based and social aspects of inappropriate AB 
use in the public, including the lowering of expec-
tations for AB prescriptions, and the highlighting 
of the dangers associated with AMR [35]. On the 
other hand, healthcare professionals’ responsibili-
ty on the matter also has to be highlighted: as the 
doctor-patient and pharmacist-patient relation-
ship is unbalanced (from the standpoint of medi-
cal information), patients will adhere to the advice 
received (also highlighted by the results of this 
study) and feed off of the inappropriate behaviors 
and attitudes of the respective healthcare profes-
sionals [17,36,37]. Thus, it may be concluded that 
without structural changes in the healthcare infra-
structure of a relevant country, true change cannot 
be attained [38]. 
Some limitations of this study must be acknowl-
edged (which were also present in the standard-
ized Eurobarometer instrument): i) some of the 
questions rely on the respondents’ memory, 
which may lead to discrepancies or bias; ii) the 
principal assumption of the study is that the 
knowledge level and attitude of patients will in-
definitely determine their practices towards ABs 
and the practices of the respondents were not 
measured directly; iii) the presence of social desir-
ability bias in some of the questions; iv) geograph-
ical limitations (the study may only represent the 
patients of the Szeged District).
5. Conclusions
As the number of available antibiotics is dwin-
dling, one of the most important steps to preserve 
the efficacy of existing drugs is the use of educa-
tional campaigns in an attempt to augment the 
health behaviour of patients. Our paper aimed at 
the assessing and understanding of AMR-related 
general population behaviour in the Szeged Dis-
trict of Hungary, in a descriptive antibiotic-related 
questionnaire, based on the methodology of the 
Special Eurobarometer reports of the European 
Commission. As a highlight to our study, higher 
education levels were associated with better knowl-
edge and attitudes, in addition, the majority of re-
spondents were not aware of the differences be-
tween bacterial and viral infections and their treat-
ment. This study has built on existing research and 
generated data which may be used for the design-
ing and implementation of awareness campaigns, 
based on the needs of the local community. 
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